loading
前日終値:
$10.97
開ける:
$10.99
24時間の取引高:
15,792
Relative Volume:
0.12
時価総額:
$204.60M
収益:
$54,000
当期純損益:
$-210.26M
株価収益率:
-13.56
EPS:
-0.79
ネットキャッシュフロー:
$-159.01M
1週間 パフォーマンス:
-1.57%
1か月 パフォーマンス:
-14.17%
6か月 パフォーマンス:
-23.90%
1年 パフォーマンス:
-66.48%
1日の値動き範囲:
Value
$10.56
$11.39
1週間の範囲:
Value
$10.49
$11.47
52週間の値動き範囲:
Value
$7.65
$32.00

Lyell Immunopharma Inc Stock (LYEL) Company Profile

Name
名前
Lyell Immunopharma Inc
Name
セクター
Healthcare (1158)
Name
電話
650 695-0677
Name
住所
201 HASKINS WAY, SOUTH SAN FRANCISCO
Name
職員
300
Name
Twitter
Name
次回の収益日
2025-03-12
Name
最新のSEC提出書
Name
LYEL's Discussions on Twitter

LYEL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
LYEL
Lyell Immunopharma Inc
10.65 209.11M 54,000 -210.26M -159.01M -0.79
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
387.16 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
582.45 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
448.18 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
702.69 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
307.64 37.96B 3.81B -644.79M -669.77M -6.24

Lyell Immunopharma Inc Stock (LYEL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-30 ダウングレード BofA Securities Buy → Underperform
2024-06-27 ダウングレード H.C. Wainwright Buy → Neutral
2023-08-28 ダウングレード JP Morgan Overweight → Neutral
2022-11-14 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-11-11 ダウングレード Goldman Buy → Neutral
2022-10-17 開始されました H.C. Wainwright Buy
2021-07-12 開始されました BofA Securities Buy
2021-07-12 開始されました Goldman Buy
2021-07-12 開始されました JP Morgan Overweight
2021-07-12 開始されました Morgan Stanley Overweight
すべてを表示

Lyell Immunopharma Inc (LYEL) 最新ニュース

pulisher
Aug 20, 2025

Trendlines Converge — Decision Point for Lyell Immunopharma Inc.Trade Volume Summary & Free High Return Stock Watch Alerts - classian.co.kr

Aug 20, 2025
pulisher
Aug 20, 2025

Lyell Immunopharma Inc. Could See a Relief Rally From SupportWeekly Market Report & Free Weekly Watchlist of Top Performers - thegnnews.com

Aug 20, 2025
pulisher
Aug 18, 2025

Can Lyell Immunopharma Inc. reach all time highs this yearMarket Activity Report & Daily Entry Point Alerts - 선데이타임즈

Aug 18, 2025
pulisher
Aug 17, 2025

What machine learning models say about Lyell Immunopharma Inc.Weekly Market Outlook & Daily Price Action Insights - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Custom strategy builders for tracking Lyell Immunopharma Inc.2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Detecting price anomalies in Lyell Immunopharma Inc. with AIWeekly Trade Recap & High Conviction Investment Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is Lyell Immunopharma Inc. stock poised for growthPortfolio Gains Report & Long Hold Capital Preservation Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Real time scanner hits for Lyell Immunopharma Inc. explained2025 Performance Recap & Free Technical Confirmation Trade Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

What’s next for Lyell Immunopharma Inc. stock priceTrade Analysis Summary & Daily Profit Maximizing Tips - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Relative strength of Lyell Immunopharma Inc. in sector analysisJuly 2025 Macro Moves & High Conviction Buy Zone Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Applying big data sentiment scoring on Lyell Immunopharma Inc.2025 Institutional Moves & Verified Entry Point Signals - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Will Lyell Immunopharma Inc. benefit from green energy policies2025 Stock Rankings & Consistent Income Trade Ideas - thegnnews.com

Aug 16, 2025
pulisher
Aug 16, 2025

Will earnings trigger a reversal in Lyell Immunopharma Inc.Trend Reversal & Reliable Trade Execution Plans - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Analyzing recovery setups for Lyell Immunopharma Inc. investorsTreasury Yields & Low Drawdown Trading Techniques - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

How to escape a deep drawdown in Lyell Immunopharma Inc.2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Lyell Immunopharma (NASDAQ:LYEL) Cut to Strong Sell at Wall Street Zen - Defense World

Aug 16, 2025
pulisher
Aug 16, 2025

Sectors Driving Future Growth for Lyell Immunopharma Inc. Stock2025 Year in Review & Reliable Volume Spike Trade Alerts - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

How to use a screener to detect Lyell Immunopharma Inc. breakoutsTrade Volume Summary & Verified Technical Trade Signals - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

A | Can Lyell Immunopharma, Inc. Rally Enough to Break Even?2025 Market Sentiment & Long-Term Safe Return Strategies - newsyoung.net

Aug 15, 2025
pulisher
Aug 15, 2025

Intraday pattern recognizer results for Lyell Immunopharma Inc.Earnings Risk Report & Detailed Earnings Play Strategies - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

What is the Moat Score of Lyell Immunopharma Inc.2025 Fundamental Recap & Fast Exit/Entry Strategy Plans - sundaytimes.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Lyell Immunopharma Secures $100M, Reports Promising LYL314 Results, and Cuts Net Loss in Q2 2025 - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Lyell Immunopharma Sells 3.75M Shares of Common Stock for Holders. - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Lyell Immunopharma Advances CAR T-Cell Therapies - TipRanks

Aug 14, 2025
pulisher
Aug 13, 2025

Lyell Immunopharma COO Hill sells $1.9k in shares By Investing.com - Investing.com Nigeria

Aug 13, 2025
pulisher
Aug 13, 2025

Lyell Immunopharma COO Hill sells $1.9k in shares - Investing.com India

Aug 13, 2025
pulisher
Aug 13, 2025

Lyell Immunopharma CSO sells $2.8k in shares By Investing.com - Investing.com Nigeria

Aug 13, 2025
pulisher
Aug 13, 2025

Lyell Immunopharma CFO Newton sells shares worth $2.7k By Investing.com - Investing.com Australia

Aug 13, 2025
pulisher
Aug 13, 2025

Lyell Immunopharma CFO Newton sells shares worth $2.7k - Investing.com

Aug 13, 2025
pulisher
Aug 13, 2025

Lyell Immunopharma CEO Seely sells shares worth $8k By Investing.com - Investing.com UK

Aug 13, 2025
pulisher
Aug 13, 2025

Can you recover from losses in Lyell Immunopharma Inc.Gold Moves & Low Risk High Reward Trade Ideas - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Lyell Immunopharma shares rise 1.04% intraday despite reporting a $42.7 million loss in Q2. - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Lyell Immunopharma: Q2 Earnings Snapshot - New Haven Register

Aug 13, 2025
pulisher
Aug 13, 2025

Identifying reversal signals in Lyell Immunopharma Inc.July 2025 Chart Watch & AI Forecasted Entry and Exit Points - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Will Lyell Immunopharma Inc. rebound enough to break evenMarket Performance Recap & Fast Gaining Stock Strategy Reports - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Lyell Immunopharma 2025 Q2 Earnings Slight Improvement in Losses Amid Revenue Drop - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Forex Signals Brief for Aug 13: Cisco, Trump Media, Lyell Earnings in Focus - FXLeaders

Aug 13, 2025
pulisher
Aug 13, 2025

Regression analysis insights on Lyell Immunopharma Inc. performanceReal-Time Setup Summary with ROI Focus - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Lyell Immunopharma Reports Positive Clinical Data, $100mln Private Placement. - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Lyell Immunopharma's Share Sale and Its Implications for Market Confidence and Capital Flexibility - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Lyell Immunopharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 12, 2025
pulisher
Aug 12, 2025

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025 - GlobeNewswire

Aug 12, 2025
pulisher
Aug 12, 2025

Lyell's New Lymphoma Treatment Outperforms Current CAR T-Cell Therapies with Superior Response Rates - Stock Titan

Aug 12, 2025
pulisher
Aug 12, 2025

What technical models suggest about Lyell Immunopharma Inc.’s comebackChart-Based Entry Confirmation for Beginners - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

How Lyell Immunopharma Inc. stock performs during market volatilityHigh Yield Growth Opportunities - mustnews.co.kr

Aug 11, 2025

Lyell Immunopharma Inc (LYEL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Lyell Immunopharma Inc (LYEL) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Hill Stephen J.
Chief Operating Officer
Aug 21 '25
Sale
10.54
1,004
10,586
15,845
Newton Charles W.
Chief Financial Officer
Aug 21 '25
Sale
10.54
1,453
15,320
15,306
Lee Gary K.
Chief Scientific Officer
Aug 21 '25
Sale
10.54
1,453
15,320
15,504
Seely Lynn
President and CEO
Aug 12 '25
Sale
10.34
406
4,197
34,828
Seely Lynn
President and CEO
Aug 11 '25
Sale
10.53
391
4,116
35,234
Hill Stephen J.
Chief Operating Officer
Aug 12 '25
Sale
10.34
94
972
8,849
Hill Stephen J.
Chief Operating Officer
Aug 11 '25
Sale
10.53
91
958
8,943
Lee Gary K.
Chief Scientific Officer
Aug 12 '25
Sale
10.34
136
1,406
8,957
Lee Gary K.
Chief Scientific Officer
Aug 11 '25
Sale
10.53
131
1,379
9,093
Newton Charles W.
Chief Financial Officer
Aug 12 '25
Sale
10.34
136
1,406
8,759
$24.43
price up icon 0.45%
$83.73
price down icon 1.14%
$26.84
price up icon 1.98%
$103.94
price down icon 1.02%
$130.93
price up icon 2.02%
biotechnology ONC
$307.00
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):